Date published: 2025-10-25

1-800-457-3801

SCBT Portrait Logo
Seach Input

OR51B2 Inhibitors

OR51B2 inhibitors are a class of chemical compounds designed to specifically target and inhibit the activity of the OR51B2 protein, which belongs to the olfactory receptor (OR) family. OR51B2, like other olfactory receptors, is a G-protein-coupled receptor (GPCR) that plays a critical role in detecting odorant molecules and initiating the signal transduction pathways responsible for the sense of smell. These receptors are primarily located in the nasal epithelium, where they interact with odorant molecules to trigger sensory responses. However, olfactory receptors such as OR51B2 are also expressed in non-olfactory tissues, indicating potential roles in additional biological processes, including cellular signaling and metabolic regulation. OR51B2 inhibitors function by binding to the receptor, preventing its activation and subsequent signaling cascade.

Inhibitors of OR51B2 are valuable tools in research for understanding the specific roles of this receptor, both in olfaction and in other physiological processes. By blocking OR51B2, researchers can investigate how its inhibition affects cellular communication, sensory perception, and broader signal transduction pathways. This enables scientists to better understand the molecular mechanisms underlying olfactory signaling and how these receptors may contribute to processes outside of olfaction. Additionally, OR51B2 inhibitors provide insight into the diverse functional roles of olfactory receptors in non-sensory tissues, allowing for a deeper exploration of their involvement in cellular functions such as tissue development, cell proliferation, and metabolic control. The study of OR51B2 inhibitors offers a more comprehensive understanding of the physiological and molecular significance of olfactory receptors beyond their traditional role in smell.

SEE ALSO...

Items 1 to 10 of 12 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Methimazole

60-56-0sc-205747
sc-205747A
10 g
25 g
$69.00
$110.00
4
(0)

Methimazole could downregulate OR51B2 expression by diminishing thyroid hormone production, which has a controlling role in the transcription of numerous genes.

Sodium Butyrate

156-54-7sc-202341
sc-202341B
sc-202341A
sc-202341C
250 mg
5 g
25 g
500 g
$30.00
$46.00
$82.00
$218.00
19
(3)

Sodium butyrate may decrease OR51B2 expression by promoting histone acetylation changes that lead to a more condensed chromatin structure, limiting gene access.

Chloroquine

54-05-7sc-507304
250 mg
$68.00
2
(0)

Chloroquine could reduce OR51B2 expression by interfering with endosomal acidification and subsequent transcription factor activity linked to gene expression.

Retinoic Acid, all trans

302-79-4sc-200898
sc-200898A
sc-200898B
sc-200898C
500 mg
5 g
10 g
100 g
$65.00
$319.00
$575.00
$998.00
28
(1)

Retinoic acid has the potential to decrease OR51B2 expression by binding to its receptors and selectively repressing transcriptional activity of the gene.

Trichostatin A

58880-19-6sc-3511
sc-3511A
sc-3511B
sc-3511C
sc-3511D
1 mg
5 mg
10 mg
25 mg
50 mg
$149.00
$470.00
$620.00
$1199.00
$2090.00
33
(3)

Trichostatin A might downregulate OR51B2 by inhibiting histone deacetylase activity, which can lead to transcriptional repression of gene clusters.

Forskolin

66575-29-9sc-3562
sc-3562A
sc-3562B
sc-3562C
sc-3562D
5 mg
50 mg
1 g
2 g
5 g
$76.00
$150.00
$725.00
$1385.00
$2050.00
73
(3)

Forskolin could lead to reduced OR51B2 expression by raising cAMP levels, which may initiate a signaling cascade hindering gene expression.

Rapamycin

53123-88-9sc-3504
sc-3504A
sc-3504B
1 mg
5 mg
25 mg
$62.00
$155.00
$320.00
233
(4)

Rapamycin might downregulate OR51B2 by blocking the mTOR signaling pathway, which is crucial for the transcription and translation processes.

PMA

16561-29-8sc-3576
sc-3576A
sc-3576B
sc-3576C
sc-3576D
1 mg
5 mg
10 mg
25 mg
100 mg
$40.00
$129.00
$210.00
$490.00
$929.00
119
(6)

PMA could decrease OR51B2 expression by activating protein kinase C, leading to altered nuclear signaling and transcriptional silencing of certain genes.

Dexamethasone

50-02-2sc-29059
sc-29059B
sc-29059A
100 mg
1 g
5 g
$76.00
$82.00
$367.00
36
(1)

Dexamethasone may inhibit OR51B2 expression by binding to glucocorticoid receptors, which can suppress the transcriptional machinery associated with the gene.

Spironolactone

52-01-7sc-204294
50 mg
$107.00
3
(1)

Spironolactone could decrease OR51B2 expression by antagonizing the mineralocorticoid receptor, leading to transcriptional repression of target genes.